Healthcare news, data and analysis
Via Investors in Healthcare
UK: Leadership changes at Pharmanovia
Pharmanovia, a global lifecycle management healthcare company, has confirmed that James Burt, is stepping down from the role of CEO. Founder, Amit Patel and COO, Sagar Patel has assumed the […]
Pharmanovia, a global lifecycle management healthcare company, has confirmed that James Burt, is stepping down from the role of CEO. Founder, Amit Patel and COO, Sagar Patel has assumed the […]
UK: Leadership changes at Pharmanovia
April 17, 2025
People
Pharma
David Murray
Guido Oelkers
James Burt
Spain: DomusVi sells Spanish mental health division to Neural
Spain-based European senior care, housing and services company DomusVi, is selling its Spanish mental health subsidiary, Mentalia Salud, to Neural, a Spain neurorehabilitation company backed by UK-based Peninsula Capital Advisors. […]
Spain-based European senior care, housing and services company DomusVi, is selling its Spanish mental health subsidiary, Mentalia Salud, to Neural, a Spain neurorehabilitation company backed by UK-based Peninsula Capital Advisors. […]
Spain: DomusVi sells Spanish mental health division to Neural
April 17, 2025
Buy Out
Healthcare
M&A
Mental Health
News
UK: Juvenescence receives strategic investment from M42
UK-based Juvenescence, a clinical-stage AI-enabled biotech company developing novel medicines to extend healthy lifespan, has received a strategic investment from Abu Dhabi-based M42, a tech-enabled integrated healthcare company created through […]
UK-based Juvenescence, a clinical-stage AI-enabled biotech company developing novel medicines to extend healthy lifespan, has received a strategic investment from Abu Dhabi-based M42, a tech-enabled integrated healthcare company created through […]
UK: Juvenescence receives strategic investment from M42
April 17, 2025
Manufacturing – Specialty Pharma
News
Pharma
Venture
Hasan Jasem Al Nowais
UK: Meribel Pharma Solutions launches with ambition to elevate pharma services
Meribel Pharma Solutions, a new, mid-size CDMO, has been launched with an integrated network across Europe, on a mission to deliver high quality solutions and services. The firm has 13 manufacturing […]
Meribel Pharma Solutions, a new, mid-size CDMO, has been launched with an integrated network across Europe, on a mission to deliver high quality solutions and services. The firm has 13 manufacturing […]
UK: Meribel Pharma Solutions launches with ambition to elevate pharma services
April 17, 2025
News
Pharma
Services – CRO/CMO/CDMO
Blue Wolf Capital Partners
Bruce Vielle
UK: Ansor closes Fund II at hard cap of £250m in oversubscribed fundraise
Ansor, a UK-based ground-up buy-and-build investor, has held the final close of its second fund, Ansor Fund II, at its hard cap of £250m (US$332m) – and approximate doubling in […]
Ansor, a UK-based ground-up buy-and-build investor, has held the final close of its second fund, Ansor Fund II, at its hard cap of £250m (US$332m) – and approximate doubling in […]
UK: Ansor closes Fund II at hard cap of £250m in oversubscribed fundraise
April 16, 2025
Dental
Healthcare
Life Sciences
M&A
Medtech – Hospital Equipment
Europe: Tom Hamer of Kilburn & Strode outlines compliance challenges and responsibilities from EU AI Act
As of February 2, AI systems that represent an “unacceptable risk” became prohibited in the EU. For companies operating in the medical device sector, the EU AI Act introduces new […]
As of February 2, AI systems that represent an “unacceptable risk” became prohibited in the EU. For companies operating in the medical device sector, the EU AI Act introduces new […]
Europe: Tom Hamer of Kilburn & Strode outlines compliance challenges and responsibilities from EU AI Act
April 16, 2025
Analysis
Legal
Life Sciences
Medtech – Diagnostics
Medtech – Healthcare IT
UK: Ben Betts appointed as new CEO at Agilio Software
Agilio Software, a UK-based provider of healthcare operations software, has appointed Dr Ben Betts as its new CEO. Agilio is acquired by backed by strategic growth investment from Five Arrows, […]
Agilio Software, a UK-based provider of healthcare operations software, has appointed Dr Ben Betts as its new CEO. Agilio is acquired by backed by strategic growth investment from Five Arrows, […]
UK: Ben Betts appointed as new CEO at Agilio Software
April 16, 2025
Digital Health/Healthtech
Healthcare
People
Agilio Software
Ben Betts
France: Five Arrows secures €2bn in commitments for latest secondary opportunities fund
Five Arrows, the alternative assets arm of Rothschild & Co, has completed fundraising for Secondary Opportunities VI, its sixth fund focused on GP-led secondary investments, securing total capital commitments of €2bn […]
Five Arrows, the alternative assets arm of Rothschild & Co, has completed fundraising for Secondary Opportunities VI, its sixth fund focused on GP-led secondary investments, securing total capital commitments of €2bn […]
France: Five Arrows secures €2bn in commitments for latest secondary opportunities fund
April 15, 2025
Buy Out
Healthcare
News
Benjamin Breard
Five Arrows
France: Mérieux Equity Partners sells stake in Theravia to Norgine
Mérieux Equity Partners (MxEP) has signed an agreement Norgine, a European specialist pharmaceutical company, to sell its majority stake in the French company Theravia. “This acquisition is a unique opportunity […]
Mérieux Equity Partners (MxEP) has signed an agreement Norgine, a European specialist pharmaceutical company, to sell its majority stake in the French company Theravia. “This acquisition is a unique opportunity […]
France: Mérieux Equity Partners sells stake in Theravia to Norgine
April 15, 2025
Buy Out
M&A
Manufacturing – Specialty Pharma
News
Pharma
Belgium: Nicolas Darnaud leaves Ardian after 12 years for Cobepa
Nicolas Darnaud has joined Cobepa, an independent, privately held investment company with offices in Brussels and New York. Before joining Cobepa, Darnaud was at France-based Ardian (formerly Axa Private Equity) […]
Nicolas Darnaud has joined Cobepa, an independent, privately held investment company with offices in Brussels and New York. Before joining Cobepa, Darnaud was at France-based Ardian (formerly Axa Private Equity) […]
Belgium: Nicolas Darnaud leaves Ardian after 12 years for Cobepa
April 15, 2025
Healthcare
People
Ardian
Belgium
Cobepa
Switzerland: Healthcare Holding Switzerland strengthens portfolio with Schaublin Medica
Healthcare Holding Switzerland, a provider of services and distributor of medical technology in Switzerland, has strengthened its portfolio with the acquisition of Schaublin Medica, a specialized distributor in cardiac and […]
Healthcare Holding Switzerland, a provider of services and distributor of medical technology in Switzerland, has strengthened its portfolio with the acquisition of Schaublin Medica, a specialized distributor in cardiac and […]
Switzerland: Healthcare Holding Switzerland strengthens portfolio with Schaublin Medica
April 15, 2025
Buy Out
Life Sciences
M&A
Medtech – Hospital Equipment
Medtech – Medical Devices and Implants
IIH talks to Philipp Ziehr on 1Q Health’s ambition to become one of Europe’s top 20 CDMOs
1Q Health, a European CDMO focusing on premium pharmaceuticals and nutraceutical supplements, is a relatively new name to the pharma service sector. Operating under the motto “Fast Track to Quality”, […]
1Q Health, a European CDMO focusing on premium pharmaceuticals and nutraceutical supplements, is a relatively new name to the pharma service sector. Operating under the motto “Fast Track to Quality”, […]
IIH talks to Philipp Ziehr on 1Q Health’s ambition to become one of Europe’s top 20 CDMOs
April 14, 2025
Analysis
Articles
Pharma
Services – CRO/CMO/CDMO
1Q Health Group
Sweden: Pär Ihrskog to join Vitrolife Group as CFO
Pär Ihrskog has been appointed CFO of Vitrolife Group, the Gothenburg-based developer and manufacturer of products for assisted reproduction, effective October 10, 2025. Ihrskog joins from Bufab Group where he currently […]
Pär Ihrskog has been appointed CFO of Vitrolife Group, the Gothenburg-based developer and manufacturer of products for assisted reproduction, effective October 10, 2025. Ihrskog joins from Bufab Group where he currently […]
Sweden: Pär Ihrskog to join Vitrolife Group as CFO
April 11, 2025
Fertility
Healthcare
Life Sciences
Medtech – Medical Devices and Implants
People
Australia: Ramsay still searching for permanent CFO as Roberts leaving date announced
Further to the leadership transition announced in January 2025, ASX-listed Ramsay Health Care has announced that CFO Martyn Roberts will leave at the end of April 2025. Deputy CFO Mike […]
Further to the leadership transition announced in January 2025, ASX-listed Ramsay Health Care has announced that CFO Martyn Roberts will leave at the end of April 2025. Deputy CFO Mike […]
Australia: Ramsay still searching for permanent CFO as Roberts leaving date announced
April 11, 2025
Healthcare
Hospitals and Clinics
People
Australia
Martyn Roberts
UK: RDi acquires Inicio Health to transform digital screening and home testing
LDC-backed RDi, a provider of data driven, automated self-sampling kits for healthcare, has acquired Inicio Health, a UK company creating solutions that improve outcomes and patient experience. The acquisition unites two […]
LDC-backed RDi, a provider of data driven, automated self-sampling kits for healthcare, has acquired Inicio Health, a UK company creating solutions that improve outcomes and patient experience. The acquisition unites two […]
UK: RDi acquires Inicio Health to transform digital screening and home testing
April 11, 2025
Buy Out
Consumer Healthcare
Diagnostics
Healthcare
Life Sciences
US: PureTech Health declines approach from Nordic Capital
US-based PureTech Health, a clinical-stage biotherapeutics company listed on Nasdaq and LSE, has rejected and approach from Nordic Capital. PureTech confirmed discussions had taken place. The share price of PureTech Health […]
US-based PureTech Health, a clinical-stage biotherapeutics company listed on Nasdaq and LSE, has rejected and approach from Nordic Capital. PureTech confirmed discussions had taken place. The share price of PureTech Health […]
US: PureTech Health declines approach from Nordic Capital
April 10, 2025
Buy Out
M&A
News
Pharma
JP Morgan
IIH talks to Paul Major at Bellevue Asset Management on the impact of US tariffs on healthcare
As global stock markets swing wildly in the wake of US tariffs and investors and manufacturers attempt to assess the likely impact of the end to decades of increasing globalisation, […]
As global stock markets swing wildly in the wake of US tariffs and investors and manufacturers attempt to assess the likely impact of the end to decades of increasing globalisation, […]
IIH talks to Paul Major at Bellevue Asset Management on the impact of US tariffs on healthcare
April 10, 2025
Analysis
Articles
Healthcare
Life Sciences
News
UK: Assura agrees £1.608bn cash bid from KKR and Stonepeak
London-listed Assura, a UK-based diversified healthcare REIT, has reached an agreement with KKR and US-based infrastructure investor, Stonepeak Partners on the terms of a recommended cash offer for the entire issued and to be […]
London-listed Assura, a UK-based diversified healthcare REIT, has reached an agreement with KKR and US-based infrastructure investor, Stonepeak Partners on the terms of a recommended cash offer for the entire issued and to be […]
UK: Assura agrees £1.608bn cash bid from KKR and Stonepeak
April 10, 2025
Buy Out
Healthcare
Hospitals and Clinics
M&A
News
Sweden: KKR acquires Karo Healthcare from EQT
The rumoured €2.5bn Karo Healthcare deal between KKR and EQT has been realised with KKR confirming the acquisition of the European consumer healthcare company, Karo, from European PE firm EQT. […]
The rumoured €2.5bn Karo Healthcare deal between KKR and EQT has been realised with KKR confirming the acquisition of the European consumer healthcare company, Karo, from European PE firm EQT. […]
Sweden: KKR acquires Karo Healthcare from EQT
April 10, 2025
Buy Out
Consumer Healthcare
Cosmetic & Aesthetics
Healthcare
M&A
Poland: Medicover expands sport and wellness offering with CityFit
Sweden-based international healthcare and diagnostic services company, Medicover has acquired CityFit, a major operator of fitness clubs in Poland. The transaction values CityFit at PLN565m (US$145m) including assumed net debt […]
Sweden-based international healthcare and diagnostic services company, Medicover has acquired CityFit, a major operator of fitness clubs in Poland. The transaction values CityFit at PLN565m (US$145m) including assumed net debt […]
Poland: Medicover expands sport and wellness offering with CityFit
April 9, 2025
Consumer Healthcare
Healthcare
M&A
News
CityFit
Sweden: KKR closes in on Karo Healthcare – reports
Global investor KKR is said to be close to acquiring Karo Healthcare, a Sweden-based company that sells and markets a portfolio of everyday healthcare products, from EQT in a deal […]
Global investor KKR is said to be close to acquiring Karo Healthcare, a Sweden-based company that sells and markets a portfolio of everyday healthcare products, from EQT in a deal […]
Sweden: KKR closes in on Karo Healthcare – reports
April 9, 2025
Buy Out
Consumer Healthcare
Healthcare
M&A
News
UK: Apposite Capital’s HCML acquires ILS
HCML, a UK provider of case management and rehabilitation services, has acquired ILS, specialists in rehabilitation case management and care for catastrophically injured children and adults. The acquisition allows HCML to […]
HCML, a UK provider of case management and rehabilitation services, has acquired ILS, specialists in rehabilitation case management and care for catastrophically injured children and adults. The acquisition allows HCML to […]
UK: Apposite Capital’s HCML acquires ILS
April 9, 2025
Buy Out
Complex Behavioural Care
M&A
News
Social Care
Germany: 1Q Health adds VivaCell Biotechnology to growing CDMO group
European CDMO, 1Q Health Group, has acquired VivaCell Biotechnology, a Germany based CRO. The acquisition marks the next step in 1Q Health Group’s mission to become the leading European CDMO […]
European CDMO, 1Q Health Group, has acquired VivaCell Biotechnology, a Germany based CRO. The acquisition marks the next step in 1Q Health Group’s mission to become the leading European CDMO […]
Germany: 1Q Health adds VivaCell Biotechnology to growing CDMO group
April 8, 2025
Buy Out
M&A
News
Pharma
Services – CRO/CMO/CDMO
France: SeqOne accelerates expansion into multi-omics with Life & Soft
France-based SeqOne, an AI-powered genomic analysis solutions company, has acquired Life & Soft, a Paris-based specialist in multi-omics data analysis and bioinformatics services. The move strengthens SeqOne’s position in Europe’s […]
France-based SeqOne, an AI-powered genomic analysis solutions company, has acquired Life & Soft, a Paris-based specialist in multi-omics data analysis and bioinformatics services. The move strengthens SeqOne’s position in Europe’s […]
France: SeqOne accelerates expansion into multi-omics with Life & Soft
April 8, 2025
Life Sciences
M&A
News
France
Life & Soft
UK: Epsilogen acquires TigaTx to create world leading pan-isotype antibody company
UK-based Epsilogen, a developer of immunoglobulin E (IgE) antibody therapeutics, has completed the acquisition of US-based TigaTx, a biotech company developing engineered immunoglobulin A (IgA) antibodies. The primary purpose of […]
UK-based Epsilogen, a developer of immunoglobulin E (IgE) antibody therapeutics, has completed the acquisition of US-based TigaTx, a biotech company developing engineered immunoglobulin A (IgA) antibodies. The primary purpose of […]
UK: Epsilogen acquires TigaTx to create world leading pan-isotype antibody company
April 7, 2025
Buy Out
M&A
Manufacturing – Specialty Pharma
News
Pharma
Our Sectors
We are experts at what we do
01
Our People
A dedicated team of executive search experts, delivering for you
The Compass Carter Osborne team are healthcare and life science experts. As a trusted advisor we bring decades of search experience and an unparalleled track record of delivery across our dedicated sectors for our investor clients – relied upon time and again to build outstanding leadership teams.
Familiar faces at key industry events, our expertise extends beyond the mere placing of people with our consultants bringing together sector leaders to address key challenges, working in partnership to produce tangible solutions.
02
Expertise
Unearthing rare talent, that drive successful exits
Responsive, adaptable, and emotionally intelligent, Compass Carter Osborne avoid the one-size-fits-all approach to ensure our clients achieve their desired outcome by presenting a broad range of intuitive, tailored solutions, based on specific needs.
03
Our Approach
Tailoring our offering,
to provide a bespoke service
Results driven, not process led, CCO avoid the conformity of a rigid process. Never assumptive, we listen and adopt an agreed approach which most closely delivers to a clients specific needs. Understanding the uniqueness of each role, our people tailor a search to bespoke requirements to ensure solutions that delivers the best possible results first time, every time.
A trusted advisor to the investment community
providing leaders advancing the healthcare and life sciences sectors
What our clients say
“Compass Carter Osborne really delivered for us in our search for a new CEO for Outcomes First Group. It was a vitally important assignment given that we were recruiting a successor for a long standing and highly successful CEO in a sector-leading business. Compass Carter Osborne went above and beyond in developing a deep understanding of the business and our requirements, and in only presenting candidates that closely met these. They think very creatively and their focus was very sharp; they particularly understood the culture of the business. The search was speedy and well organised, with a very high standard of verbal and written feedback. They have a granular knowledge of the sector and because of the way in which they work, we were fully involved throughout and achieved a great result. A really excellent search – thank you.”
Outcomes First Group – Chair
“Compass Carter Osborne started from the very beginning with a detailed, professional explanation of the available position. They spent time to present the great opportunity and chance to accelerate my career but at the same time, the challenge, and the strong expectation from their client.”
Hengrui Therapeutics – VP, Head Biological Drug Discovery
“Compass Carter Osborne delivered on a key appointment for the PFA and the wider football industry. It was a complex brief involving creating an entirely new position. The role was vitally important, with the successful candidate taking on a sensitive and multifaceted responsibility across CTE, concussion and brain health in professional football. CCO led a comprehensive and exhaustive process, developing a deep understanding of the union’s requirements and using his expert knowledge to help scope and evolve the brief throughout the search. The entire process was professional, efficient and well organised, with consistent communication and feedback at every stage.”
The Professional Footballers Association (PFA) – Chief Executive Officer
“I have been so impressed by Luke’s integrity, clear purpose and drive to achieve for his clients. Luke has worked with Priory on a number of things but more recently to source two independent Non Executive Directors and a Director of Talent Acquisition. He has kept us informed, fielded some great candidates and follows up at each stage, even when they have started. I would really recommend him if you are searching for high calibre individuals.”
Priory Group – Chief Executive Officer
“I recently had the pleasure of being appointed to an independent healthcare provider as a NED after being put forward for the role by Luke. Throughout the whole recruitment process I was treated with respect and felt valued. I was particularly impressed with the follow up support after the decision to appoint me, which I have never experienced from other search companies. Luke continued to check in with me to ensure my onboarding went smoothly and that I had settled into the role. Overall, a highly professional and comprehensive approach delivered personally by Luke.”
Priory – Independent Non-Executive Director
“Luke was absolutely brilliant along the journey. He acted as a real partner and was able to answer to all my questions in order to get comfortable with the decision of making the change. His expertise and knowledge of the sector really came out along the process. Most importantly, he was always available when I needed him to be, which is something I valued a lot. In summary, I couldn’t recommend him and Compass Carter Osborne enough.”
AniCura – Group Chief Operating Officer
“We worked with Compass Carter Osborne in the search for our Chief Financial Officer and from the start it was clear they were a good choice of partner. A focus on understanding our needs as a business, and mine personally as a CEO were front of mind for Paul and Kieran. They took the time to listen, understand and not only focus on the functional aspects of the role – but critically, the team fit and culture we are building.
Process, structure and follow-through were like clockwork, and the quality of candidates were of a consistently high-level. I would highly recommend Compass Carter Osborne.”
Renaiss Health – Chief Executive Officer
“I’ve known Tarquin for over 15 years, during which time he has delivered a number of executive assignments at senior level, including COO/executive team and senior management roles in scientific/professional disciplines (his network in the biotech/life-sciences sector is second-to-none!). He works hard to truly understand both the candidate brief and the culture of the company, sets realistic expectations and retains regular contact as an assignment progresses, always providing thorough updates and pragmatic advice. He has the highest levels of professionalism and integrity – he really is a pleasure to work with.”
One Nucleus – Director
“Jamie did a great job – he really took the time to understand our business, our needs and what we were looking for. We knew our brief was specific, yet Jamie met all our expectations with the search. He maintained a high standard of communication and meticulous attention to detail throughout the process. I would recommend Jamie and the Compass Carter Osborne team without hesitation.”
Melrose Education – Chair & CEO
“Our recent work with Compass Carter Osborne was exceptional. The search was perfectly organised, response times were swift, and due to the consultant market knowledge and network, we quickly found our ideal candidate.”
Schoen Clinic – Member of Group Executive
